| Product Code: ETC9561664 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden PCR-based Infectious Diseases Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden PCR-based Infectious Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden PCR-based Infectious Diseases Market - Industry Life Cycle |
3.4 Sweden PCR-based Infectious Diseases Market - Porter's Five Forces |
3.5 Sweden PCR-based Infectious Diseases Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Sweden PCR-based Infectious Diseases Market Revenues & Volume Share, By Infection, 2021 & 2031F |
3.7 Sweden PCR-based Infectious Diseases Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.8 Sweden PCR-based Infectious Diseases Market Revenues & Volume Share, By PCR Technology, 2021 & 2031F |
3.9 Sweden PCR-based Infectious Diseases Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.10 Sweden PCR-based Infectious Diseases Market Revenues & Volume Share, By Testing, 2021 & 2031F |
3.11 Sweden PCR-based Infectious Diseases Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden PCR-based Infectious Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Sweden |
4.2.2 Growing awareness about the benefits of PCR-based testing over traditional methods |
4.2.3 Technological advancements in PCR technology leading to improved accuracy and efficiency |
4.3 Market Restraints |
4.3.1 High cost associated with PCR-based testing compared to conventional methods |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Sweden |
4.3.3 Stringent regulations and approval processes for PCR-based diagnostic tests |
5 Sweden PCR-based Infectious Diseases Market Trends |
6 Sweden PCR-based Infectious Diseases Market, By Types |
6.1 Sweden PCR-based Infectious Diseases Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Tuberculosis PCR Test, 2021- 2031F |
6.1.4 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Hepatitis PCR Test, 2021- 2031F |
6.1.5 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Human Immunodeficiency Virus (HIV) PCR Test, 2021- 2031F |
6.1.6 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Influenza PCR Test, 2021- 2031F |
6.1.7 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Human Papilloma Virus (HPV) PCR Test, 2021- 2031F |
6.2 Sweden PCR-based Infectious Diseases Market, By Infection |
6.2.1 Overview and Analysis |
6.2.2 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Viral Infection, 2021- 2031F |
6.2.3 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Respiratory Tract Infection, 2021- 2031F |
6.2.4 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Sexually Transmitted Infection, 2021- 2031F |
6.2.5 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Hospital Acquired Infections, 2021- 2031F |
6.2.6 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Other Infections, 2021- 2031F |
6.3 Sweden PCR-based Infectious Diseases Market, By Pathogen |
6.3.1 Overview and Analysis |
6.3.2 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Viral, 2021- 2031F |
6.3.3 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Bacterial, 2021- 2031F |
6.3.4 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Fungal, 2021- 2031F |
6.3.5 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Protozoa, 2021- 2031F |
6.3.6 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden PCR-based Infectious Diseases Market, By PCR Technology |
6.4.1 Overview and Analysis |
6.4.2 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By RT PCR, 2021- 2031F |
6.4.3 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Multiplex PCR, 2021- 2031F |
6.4.4 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden PCR-based Infectious Diseases Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5.4 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Adults, 2021- 2031F |
6.6 Sweden PCR-based Infectious Diseases Market, By Testing |
6.6.1 Overview and Analysis |
6.6.2 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Laboratory Based Testing, 2021- 2031F |
6.6.3 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Point of Care Testing, 2021- 2031F |
6.7 Sweden PCR-based Infectious Diseases Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.3 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.5 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.6 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Clinics, 2021- 2031F |
6.7.7 Sweden PCR-based Infectious Diseases Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
7 Sweden PCR-based Infectious Diseases Market Import-Export Trade Statistics |
7.1 Sweden PCR-based Infectious Diseases Market Export to Major Countries |
7.2 Sweden PCR-based Infectious Diseases Market Imports from Major Countries |
8 Sweden PCR-based Infectious Diseases Market Key Performance Indicators |
8.1 Percentage increase in the adoption rate of PCR-based testing for infectious diseases in Sweden |
8.2 Number of research and development investments in PCR technology within the country |
8.3 Rate of improvement in turnaround time for PCR test results |
9 Sweden PCR-based Infectious Diseases Market - Opportunity Assessment |
9.1 Sweden PCR-based Infectious Diseases Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Sweden PCR-based Infectious Diseases Market Opportunity Assessment, By Infection, 2021 & 2031F |
9.3 Sweden PCR-based Infectious Diseases Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.4 Sweden PCR-based Infectious Diseases Market Opportunity Assessment, By PCR Technology, 2021 & 2031F |
9.5 Sweden PCR-based Infectious Diseases Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.6 Sweden PCR-based Infectious Diseases Market Opportunity Assessment, By Testing, 2021 & 2031F |
9.7 Sweden PCR-based Infectious Diseases Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden PCR-based Infectious Diseases Market - Competitive Landscape |
10.1 Sweden PCR-based Infectious Diseases Market Revenue Share, By Companies, 2024 |
10.2 Sweden PCR-based Infectious Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here